cefadroxil + fluconazole

Cefadroxil + fluconazole is a combination of two pharmaceutical agents, each with distinct mechanisms of action. Cefadroxil is a first-generation cephalosporin antibiotic that acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. It is primarily used for the treatment of various bacterial infections such as urinary tract infections, skin and soft tissue infections, pharyngitis, and tonsillitis[2][5]. Fluconazole is a triazole antifungal agent that inhibits fungal cytochrome P450 enzyme 14α-demethylase (CYP51), thereby disrupting ergosterol synthesis in the fungal cell membrane. This results in increased cellular permeability and ultimately fungal cell death. Fluconazole is indicated for the treatment of systemic and superficial fungal infections including candidiasis[3]. The combination may be considered when both bacterial and fungal pathogens are suspected or confirmed.